Details of the Drug Reposition

General Information of This Drug (ID: DMRR5P0)

Drug Name
DCCR   DMRR5P0
Synonyms Diazoxide choline controlled-release
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Prader-Willi syndrome DISYWMLU LD90.3 Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Dyslipidemia DISUYOOU 5C80-5C81 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03440814) A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT01211847) Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia. U.S. National Institutes of Health.